Cargando…

Observational study of the outcomes and costs of initiating maintenance therapies in patients with moderate exacerbations of COPD

BACKGROUND: There are limited data describing patients with moderate COPD exacerbations and evaluating comparative effectiveness of maintenance treatments in this patient population. The study examined COPD patients with moderate COPD exacerbations. COPD-related outcomes were compared between patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalal, Anand A, Shah, Manan B, D’Souza, Anna O, Lunacsek, Orsolya E, Nagar, Saurabh P, Crater, Glenn D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490761/ https://www.ncbi.nlm.nih.gov/pubmed/22651541 http://dx.doi.org/10.1186/1465-9921-13-41

Ejemplares similares

Clinical and economic outcomes for patients initiating fluticasone propionate/salmeterol combination therapy (250/50 mcg) versus anticholinergics in a comorbid COPD/depression population
por: Dalal, Anand A, et al.
Publicado: (2012)

Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease
por: Chatterjee, Arjun, et al.
Publicado: (2012)

COPD affects worker productivity and health care costs
por: Patel, Jeetvan G, et al.
Publicado: (2018)

Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States
por: Diette, Gregory B, et al.
Publicado: (2015)

Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population
por: Coutinho, Anna D, et al.
Publicado: (2016)

Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United States
por: Patel, Jeetvan G, et al.
Publicado: (2014)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD
por: Yawn, Barbara P, et al.
Publicado: (2010)

Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy
por: Palli, Swetha R, et al.
Publicado: (2021)

Factors associated with exacerbation in mild- to-moderate COPD patients
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Association between COPD exacerbations and lung function decline during maintenance therapy
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Exacerbations of COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Maintained therapeutic effect of revefenacin over 52 weeks in moderate to very severe Chronic Obstructive Pulmonary Disease (COPD)
por: Donohue, James F., et al.
Publicado: (2019)

Interferon therapy for preventing COPD exacerbations
por: Mehta, Meenu, et al.
Publicado: (2020)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Clinical and economic outcomes in an observational study of COPD maintenance therapies: multivariable regression versus propensity score matching
por: Roberts, Melissa H, et al.
Publicado: (2012)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Hospitalization Costs for Patients Undergoing Orthopedic Surgery Treated With Intravenous Acetaminophen (IV-APAP) Plus Other IV Analgesics or IV Opioid Monotherapy for Postoperative Pain
por: Maiese, Brett A., et al.
Publicado: (2016)

Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study
por: Donohue, James F, et al.
Publicado: (2014)

Determinants of change in physical activity during moderate-to-severe COPD exacerbation
por: Esteban, Cristóbal, et al.
Publicado: (2016)

COPD management costs according to the frequency of COPD exacerbations in UK primary care [Corrigendum]
Publicado: (2014)

Exacerbations of COPD
por: Viniol, Christian, et al.
Publicado: (2018)

Initiation of triple therapy maintenance treatment among patients with COPD in the US
por: Simeone, Jason C, et al.
Publicado: (2016)

Association Between Adherence to Maintenance Medication in Patients with COPD and Acute Exacerbation Occurrence and Cost in China: A Retrospective Cohort Database Study
por: Chen, Rongchang, et al.
Publicado: (2020)

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
por: W. H. Kocks, Janwillem, et al.
Publicado: (2022)

COPD exacerbation frequency and its association with health care resource utilization and costs
por: Dhamane, Amol D, et al.
Publicado: (2015)

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
por: Wilson, Robert, et al.
Publicado: (2015)

Necessity of amoxicillin clavulanic acid in addition to prednisolone in mild-to-moderate COPD exacerbations
por: Brusse-Keizer, Marjolein, et al.
Publicado: (2014)

Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
por: Singh, Dave, et al.
Publicado: (2019)

Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients
por: Løkke, Anders, et al.
Publicado: (2022)

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease
por: Dalal, Anand A, et al.
Publicado: (2011)

Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy
por: Moretz, Chad, et al.
Publicado: (2020)

Consolidation and Exacerbation of COPD
por: Hurst, John R.
Publicado: (2018)

Acute Exacerbation of COPD
por: Lief, Lindsay, et al.
Publicado: (2019)

Management of exacerbations of COPD
por: Seemungal, Terence, et al.
Publicado: (2003)

Acute Exacerbations of COPD
por: Wedzicha, J.A.
Publicado: (2002)

Acute Exacerbations of COPD
por: Wedzicha, Jadwiga A.
Publicado: (2009)

Acute Exacerbation of COPD
por: Pappas, Dominic, et al.
Publicado: (2023)

PRIMUS – Prompt Initiation of Maintenance Therapy in the US: A Real-World Analysis of Clinical and Economic Outcomes Among Patients Initiating Triple Therapy Following a COPD Exacerbation
por: Tkacz, Joseph, et al.
Publicado: (2022)

Role of microparticles derived from monocytes, endothelial cells and platelets in the exacerbation of COPD
por: Tőkés-Füzesi, Margit, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d6eph29llvhoqdq3i3du2rdh3o